Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S.

With no vaccines or treatments for COVID-19 on the market, many healthcare companies are evaluating existing drug treatments to see if they could be effective in helping COVID-19 patients. Bayer (OTC: BAYRY) is preparing to donate a large supply of an older malaria drug to the U.S. government, according to Axios.